Brind.

Spago Nanomedical AB applies for removal from Nasdaq Stockholm trading

1 report, 1 independent Updated Fri 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Spago Nanomedical AB announced that its board of directors resolved to apply for the removal of its shares from trading on Nasdaq First North Growth Market, pending approval from its shareholders. Nasdaq Stockholm AB subsequently granted the company's shares observation status, in accordance with Nasdaq First North Growth Market Rulebook 6.3.1 (d).

From finanznachrichten.de

Why it matters

Some supportBrind's analysis of the reports

The application for removal from the Nasdaq First North Growth Market affects the company's ability to trade publicly on the exchange. Nasdaq Stockholm AB is operated by Nasdaq, which manages the exchange where the listing is located.

From finanznachrichten.de

Who's involved

  • Nasdaq Stockholm ABThe stock exchange where Spago Nanomedical AB is seeking removal from trading.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped